Population attributable risk for diabetes associated with excess weight in Tehranian adults: a population-based cohort study by Hosseinpanah, Farhad et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Public Health
Open Access Research article
Population attributable risk for diabetes associated with excess 
weight in Tehranian adults: a population-based cohort study
Farhad Hosseinpanah*1, Mehdi Rambod1 and Fereidoun Azizi2
Address: 1Obesity Research Center, Research Institute for Endocrine Sciences, Shaheed Beheshti University of Medical Sciences, Tehran, Iran and 
2Endocrine Research Center, Research Institute for Endocrine Sciences, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
Email: Farhad Hosseinpanah* - fhospanah@erc.ac.ir; Mehdi Rambod - rambod@ams.ac.ir; Fereidoun Azizi - azizi@erc.ac.ir
* Corresponding author    
Abstract
Background: Little evidence exists regarding the magnitude of contribution of excess weight to
diabetes in the Middle East countries. This study aimed at quantification of the impact of overweight
and obesity on the incidence of type 2 diabetes mellitus (T2DM) at a population level in Tehran,
Iran.
Methods: Using data of a population-based short-term cohort study in Iran, which began in 1997
with 3.6-year follow-up, we calculated the adjusted odds ratios (OR) and population attributable
risks (PAR) of developing T2DM, i.e. the proportion of diabetes that could have been avoided had
overweight and/or obesity not been present in the population.
Results: Of the 4728 subjects studied, aged ≥ 20 years, during the 3.6-year follow-up period, 3.8%
(n = 182) developed T2DM. This proportion was 1.4%, 3.6%, and 7.8% for the normal, overweight,
and obese subjects, respectively. When compared to normal BMI, the adjusted ORs for incident
diabetes were 1.76 [95% confidence interval (CI) 1.07 to 2.89] for overweight and 3.54 (95% CI
2.16 to 5.79) for obesity. The PARs adjusted for family history of diabetes, age, triglycerides, systolic
blood pressure was 23.3% for overweight and 37.1% for obesity. These figures were 7.8% and
26.6% for men and 35.3% and 48.3% for women, respectively.
Conclusion: Incident T2DM is mainly attributable to excess weight, significantly more so in
Tehranian women than men. Nonetheless, the contribution of excess weight in developing T2DM
was lower in our short-term study than that reported in long-term periods. This probably reflects
the significant role of other risk factors of T2DM in a short-term follow-up. Hence, prevention of
excess weight probably should be considered as a major strategy for reducing incidence of T2DM;
the contribution of other risk factors in developing T2DM in short-term period deserve to be
studied and be taken into account.
Background
Progressive increment of body weight of the population is
a major problem faced by the public health systems in a
number of countries. Today, more than 1.1 billion adults
worldwide are overweight, of which 312 million are obese
[1]. In the past 20 years, the rates of obesity have tripled
in developing countries adopting Western lifestyles. In
Iran, as well as other developing countries, the prevalence
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of overweight and obesity shows a rapid increasing pat-
tern during recent years [2].
Obesity and overweight are associated with a number of
co-morbidities [3]. A higher body-mass index (BMI) has
been shown to account for up to 16% of the global bur-
den of disease, expressed as a percentage of disability-
adjusted life-years. In the developed world, 2 to 7% of
total health care costs are attributable to obesity. Moreo-
ver, the growing prevalence of type 2 diabetes, cardiovas-
cular disease, and some cancers are tied to excess weight.
Several studies have found that the single measure of
being overweight or obese in early middle age predicts
increased cardiovascular disease risk two or three decades
later [4-7] and that the increase in the prevalence of type
2 diabetes is closely linked to the upsurge in obesity [8-
11]. Based on the fact that adipose tissue is an important
endocrine organ, it is not surprising that overweight indi-
viduals are at increased risk of diabetes [12,13]. Indeed,
obesity is the strongest risk factor for diabetes [14]. A 20-
year follow-up of Whickham study found that BMI is an
independent predictor of diabetes [15]. Another study
from Japan revealed that increases in BMI of 1 kg/m2
(equal to body-weight gain of 2.4 to 2.9 kg) may raise the
risk of diabetes by 25% [14]. BMI, even within the non-
obese level, is still a dose dependent risk factor for diabe-
tes mellitus [14,16]. A recent survey of a Scottish popula-
tion reported that within the normal weight group, the
risk of developing diabetes was 2 to 3 times greater in the
higher half of normal BMI range in comparison to the
lower half [17].
Considering the fact that little evidence exists regarding
the contribution of excess weight to diabetes in the Mid-
dle East countries, in this cohort study with 3.6-years fol-
low-up, we examined the strength of association between
excess weight and incident type 2 DM in a short term
period, using data of a large population-based cohort
study conducted in Iran [18]. Moreover, we aimed at
quantifying the adjusted population attributable risk per-
centage of developing type 2 DM, an estimate that can
give us an idea of the extent of diabetes mellitus caused by
overweight and obesity.
Methods
Subjects and Design
The Tehran Lipid and Glucose Study (TLGS) is a study
being conducted to determine the prevalence of non-com-
municable diseases and the risk factors of atherosclerosis
among Tehran's urban population and to develop popu-
lation-based measures and lifestyle modifications to
decrease the prevalence and prevent the rising trend of
diabetes mellitus and dyslipidemia [18,19]. The design of
this study includes two major components, a cross-sec-
tional prevalence study of cardiovascular disease and
associated risk factors and then, a prospective 20-year fol-
low-up in several phases, at approximately 3.6-year inter-
vals. A multi-stage stratified cluster random sampling
technique was used to select 15005 people, aged 3 years
and over, from urban district 13 of Tehran, the capital of
the Iran; the district is located in the center of Tehran and
the age distribution of its population is representative of
the overall population of Tehran. During sampling, the
list of all households under the coverage of the district's
three healthcare centers (the official bodies responsible
for vaccination programs and collection of health-related
statistics in a district) was used. Then, a random sample of
households, stratified according to healthcare centers to
achieve a distribution similar to the original population,
was chosen, and from each household, all members
above the age of three were recruited. The study began in
December 1997 and the cross-sectional phase completed
in 2000; the first follow-up survey began in 2001 and
completed in 2004. After excluding subjects aged < 20
years (n = 4642), those with known or newly diagnosed
type 2 diabetes (n = 1164), those with missed values of
weight, height, or other variables (n = 349), or lost to fol-
low-up (n = 4122), data of 4728 subjects with a complete
3.6-year follow-up was used in this cohort study. In com-
parison to those completed the follow-up, individuals lost
to follow-up had lower value of systolic blood pressure
(119 vs. 117 mmHg), BMI (26.9 vs. 26.2 Kg/m2), waist
circumference (88.2 vs. 86.5 cm), triglycerides (1.88 vs.
1.78 mmol/L), fasting plasma glucose (4.99 vs. 4.94
mmol/L), and 2-h postchallenge plasma glucose (5.94 vs.
5.83 mmol/L).
At the beginning of the cross-sectional phase, all partici-
pants provided written informed consent, which was
approved by the institutional ethics committees (Research
Institute for Endocrine Sciences) and was conducted in
accordance with the principles of the Declaration of Hel-
sinki. Thereafter, collection of demographic data and
anthropometric examinations were undertaken by trained
general physicians. Weight and height were measured
with subjects wearing normal indoor clothing, but not
shoes. Weight was recorded using a Seca 707 weighing
machine (range: 0.1–150 kg) with an accuracy of up to
100 gr. The machine was regularly checked for precision
after every 10 measurements. Height was measured with-
out shoes using a tape stadiometer with a minimum
measurement of 1 mm. Body mass index (BMI) was calcu-
lated by dividing weight (in kilograms) by height squared
(in meters). To measure systolic blood pressure (SBP) and
diastolic blood pressure (DBP), participants were initially
made to rest for 15 min; then a qualified physician meas-
ured blood pressure twice in a seated position using a
standard mercury sphygmomanometer on the right arm
and, the mean of the two measurements was considered
as the participant's blood pressure. Fasting plasma glucoseBMC Public Health 2007, 7:328 http://www.biomedcentral.com/1471-2458/7/328
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(FPG), 2-hour postchallenge plasma glucose (2h-PG) and
serum lipids were measured at the TLGS research labora-
tory on the day of blood collection. Details of the bio-
chemical measurements are published elsewhere [20].
Definitions
BMI was first categorized according to the World Health
Organization (WHO) definitions of underweight (< 18.5
kg/m2), normal (18.5 to < 25 kg/m2), overweight (25 to <
30 kg/m2), and obese (≥ 30 kg/m2) [21]; excluding the
underweight subjects, the other categories BMI were then
divided into two subcategories (18.5 to < 22.5 kg/m2 and
22.5 to < 25 kg/m2; 25 to < 27.5 kg/m2 and 27.5 to < 30
kg/m2; 30 to < 32.5 kg/m2 and ≥ 32.5 kg/m2). Family his-
tory of diabetes was considered as positive if any of the
first-degree relatives of the subject had diabetes. For the
current study, diabetes was defined as FPG ≥ 7.0 mmol/L
and/or 2h-PG ≥ 11.1 mmol/L or current use of oral anti-
hyperglycemic medications. Smoking statuses were
defined according to WHO guidelines [22]; current
smoker was defined as a person who smokes cigarettes
daily or occasionally; ex-smoker was defined as a person
who was formerly a daily or occasional smoker, but cur-
rently did not smoke at all and a non-smoker was defined
as a person who has never smoked before or has smoked
very little in the past.
Statistical Analyses
Continuous data are expressed as mean ± SD and categor-
ical data are expressed as percentage. Continuous and cat-
egorical variables were compared using the student t-test
and the χ2 test, respectively. Differences between more
than two groups were analyzed using ANOVA with the
Tukey post hoc test. Trends of proportions were examined
using linear-by-linear χ2 test and trends of continuous
data were examined using simple linear regression mod-
els. Logistic regression models were used to assess the
unadjusted and adjusted odds ratios (OR) of incident dia-
betes across categories of BMI [normal (as reference cate-
gory), overweight, and obese] in all the population and
then in each sex, separately. Family history of diabetes,
age (at the cross-sectional phase of the study), triglycer-
ides, and systolic blood pressure were entered in stepwise
manner to obtain adjusted ORs of incident diabetes.
While some of these variables, such as hypertriglyceri-
demia, may not have confounding roles; they might how-
ever be on the causal pathway from elevated BMI to
metabolic syndrome and type 2 diabetes. Therefore, the
adjusted odds ratios yield a minimal estimate of the
causal effect of BMI. Population attributable risks were
calculated with the use of the formula (P(OR-1)χ[P(OR-
1)+1]) × 100, where P is the prevalence of the overweight
or obesity in Tehranian population (exposed to the risk
factor) [2] and OR is the adjusted odds ratio [23]. The 95
percent confidence interval (CI) was calculated by deter-
mining the 95% CI for log(P [OR-1]) on the basis of the
standard errors for P and OR and transforming back to the
95% CI for the population attributable risk. All statistical
analyses were performed using SPSS software (version
13.0; SPSS Inc. Chicago, Ill, USA). All statistical tests were
two sided and differences with probability values < 0.05
were considered statistically significant.
Results
Of the 4728 subjects studied, aged 42.9 ± 13.6 years at the
beginning of the study, 41.5% (n = 1961) were male and
58.5% (n = 2767) were female. Overall, 42.3% (n = 2001)
were overweight and 23.7% (n = 1121) were obese. The
proportion of obesity was significantly higher in women
than in men (29.8% vs. 15.1%, respectively;P < 0.001).
Furthermore, underweight subjects were more likely to be
current smokers (16.7%) and obese subjects were more
likely to be non-smoker (87.1%) (Linear-by-linear associ-
ation χ2 = 44.4, P < 0.001). Also, a positive family history
of diabetes was reported more in obese subjects than in
normal and underweight ones (P < 0.001). Systolic and
diastolic blood pressures as well as serum triglycerides
were positively related to BMI category (Table 1). Almost
similar patterns were observed in men (Additional file 1)
and women (Additional file 2).
During the 3.6-year follow-up period, 3.8% of the partic-
ipants (n = 182) developed diabetes, of whom, 59.9% (n
= 109) were women. Of the normal, overweight, and
obese subjects 1.4%, 3.6%, and 7.8% developed diabetes,
respectively, while none of the 90 underweight subjects
became diabetic during the follow-up period. Hence, we
excluded the underweight subjects from additional analy-
ses.
The ORs for incident diabetes were 2.57 (95% CI 1.60 to
4.13) for overweight and 5.79 (95% CI 3.63 to 9.23) for
obesity when compared to normal BMI. Table 2 shows
that stepwise adjustments for family history of diabetes,
age, triglycerides, and systolic blood pressure attenuated
the ORs of incident diabetes in overweight and obese sub-
jects, an attenuation which was greater in the obese than
in the overweight group and also, was less when adjusted
for systolic blood pressure than the other variables (Table
2). The same pattern was observed in both sexes. Further-
more, the crude and adjusted ORs were higher in women
than men for both overweight and obese participants.
Adjusted ORs for incidence diabetes in overweight men
were not statistically significant.
Population attributable risk percentages comparing over-
weight and obesity with normal BMI (< 25 kg/m2) and
based on odds ratios obtained from the models adjusted
for family history of diabetes, age, triglycerides, and systo-
lic blood pressure were 23.3% (95% CI 21.3% to 25.3%)BMC Public Health 2007, 7:328 http://www.biomedcentral.com/1471-2458/7/328
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and 37.1% (95% CI 36.2% to 37.9%), respectively. That
is 60.4% of total incident of T2DM could be attributed to
excess weight in the general population of Tehran; while,
this figure was 83.6% in women but 34.4% in men.
Discussion
This study shows that in an urban population during a
short period of follow-up, there is a strong association
between excess weight and risk of diabetes; despite the
association being reduced by adjustment of some well
known related factors, it remained considerable. In gen-
eral, more than a half of the disease burden of diabetes
could be attributed to excess weight. In our study, further-
more, compared with normal individuals, the adjusted
odds ratios for incident type 2 DM for overweight and
obese individuals were 1.76 and 3.54, respectively. More-
over, the adjusted population attributable risk of develop-
ing type 2 DM for overweight was 23.3% and for obesity
was 37.1%. Noticeably, while in women, 83.6% of new
cases of diabetes could be attributed to excess weight, in
men, almost one third of incident diabetes was attributed
to overweight or obesity.
These findings are in accordance with the results of previ-
ous studies, which have consistently demonstrated the
association between BMI and increased risk of diabetes [8-
11,15]. These studies differ in terms of age and sex of their
study population, length of follow-up time, and the vari-
ables selected for adjustment. Studies with short follow-
up, similar to ours, have reported strong relationships
between excess weight and the risk of developing diabetes.
During a 5-year follow-up in a cohort of 51529 male,
health professionals, 40–75 years of age, those with a BMI
of 35 and over had a multivariate adjusted relative risk of
42.1 (CI 95% 22 to 86) compared with men who had a
BMI < 23 [8]. In our study with shorter follow-up time
(i.e. 3.6 years) and after adjustment for age, family history
of diabetes, triglycerides and systolic blood pressure,
obese individuals with average age of 45.4 years, had a 3.5
times greater risk than those who had BMI < 25 kg/m2 at
baseline. Other studies with longer follow-ups have also
demonstrated this association. A study of Scottish men
and women, aged 45–64 years, with follow-ups of over 28
years, reported an adjusted odds ratio equal to 18.5 for an
obese group in comparison to a normal weight group
[17]. The fat cell can be considered as a type of endocrine
cell, and adipose tissue an endocrine organ [24]. Adi-
pocytes secrete a number of adipocyte hormones and
cytokines. These adipocyte hormones and adipokines
therefore may increase the risk of diabetes via several
pathways such as increasing insulin resistance [24]. In
addition, several studies have shown that in high-risk
populations, weight loss can reduce the risk of diabetes.
The Diabetes Prevention Program Research Group study
found that lifestyle interventions implemented over 2.8
years reduced the incidence of diabetes by 58% [25]. Like-
wise, a modest weight loss of one kg was associated with
a 33% lower risk of diabetes [16].
Although, the association between BMI and increased risk
of diabetes was significant in the population studied, this
association was stronger in women than men; the crude
and adjusted ORs being almost 1.5 to 2 times higher in
women than men (table 2). This can be explained by the
fact that obesity was more prevalent in women. Moreover,
lower levels of physical activity in women than men,
weight gains in pregnancy and not returning to the opti-
mal weight, may be other causes of the higher rate of obes-
ity and incident diabetes in women [2]. This
interpretation is in accordance with previous findings
Table 1: General characteristics and biochemical variables among the four categories of body mass index (BMI)
Variable BMI Category (kg/m2)
All Underweight < 18.5 Normal 18.5 to < 25 Overweight 25 to < 30 Obese ≥ 30 P for trend
Number (%) 4728 (100) 90 (1.9) 1516 (32.1) 2001 (42.3) 1121 (23.7)
Age (years) 42.9 ± 13.6 34.3 ± 14.7 40.0 ± 14.4 44.0 ± 13.1 45.4 ± 12.1 < 0.001
Female (%) 58.5 56.7 49.4 57.1 73.6 < 0.001
Family history of diabetes (%) 27.0 17.2 23.9 28.0 30.1 < 0.001
Current cigarette smoker (%) 11.9 16.7 15.5 11.3 7.5 < 0.001
Non-smoker (%) 81.2 78.9 77.3 81.0 87.1 < 0.001
Systolic blood pressure (mmHg) 119 ± 18 105 ± 13 114 ± 16 120 ± 18 124 ± 19 < 0.001
Diastolic blood pressure (mmHg) 78 ± 10 70 ± 8 74 ± 10 78 ± 10 82 ± 10 < 0.001
Fasting plasma glucose (mmol/L) 5.00 ± 0.54 4.74 ± 0.39 4.88 ± 0.51 5.03 ± 0.54 5.13 ± 0.56 < 0.001
2-hour postchallenge plasma glucose (mmol/L) 5.95 ± 1.64 4.94 ± 1.33 5.50 ± 1.48 6.07 ± 1.64 6.45 ± 1.68 < 0.001
Triglycerides (mmol/L) 1.88 ± 1.17 1.00 ± 0.50 1.50 ± 0.92 2.03 ± 1.25 2.21 ± 1.22 < 0.001
Total cholesterols (mmol/L) 5.44 ± 1.16 4.56 ± 0.94 5.08 ± 1.08 5.54 ± 1.14 5.80 ± 1.15 < 0.001
HDL-C (mmol/L) 1.09 ± 0.28 1.29 ± 0.31 1.13 ± 0.29 1.08 ± 0.28 1.07 ± 0.27 < 0.001
LDL-C (mmol/L) 3.49 ± 0.97 2.81 ± 0.86 3.26 ± 0.93 3.56 ± 0.96 3.72 ± 0.95 < 0.001
HDL-C, High density lipoprotein-cholesterol; LDL-C, Low density lipoprotein cholesterolB
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Table 2: Odds ratios for incident diabetes in 3.6-year follow-up in 4638 subjects (1922 men and 2716 women) without diabetes at baseline by the three main categories of body 
mass index (BMI)
Total (n = 4638) Men (n = 1922) Women (n = 2716)
BMI (kg/m2) 18.5 to < 25 25 to < 30 ≥ 30 18.5 to < 25 25 to < 30 ≥ 30 18.5 to < 25 25 to < 30 ≥ 30
Number (%) 1516 2001 1121 767 859 296 749 1142 825
Number of incident diabetes (%) 23 (1.4) 72 (3.6) 87 (7.8) 15 (2.0) 32 (3.7) 26 (8.8) 8 (1.1) 40 (3.5) 61 (7.4)
Unadjusted odds ratios (95% CI) 1 2.57 (1.60–4.13) 5.79 (3.63–9.23) 1 1.9 (1.04 – 3.61) 4.83 (2.52 – 9.25) 1 3.36 (1.57–7.22) 7.39 (3.52–15.56)
Adjusted odds ratios (95% CI)
Family history of diabetes (FHD) 1 2.48 (1.53–4.03) 5.36 (3.32–8.65) 1 1.82 (0.95 – 3.47) 4.69 (2.40–9.15) 1 3.27 (1.52–7.03) 6.57 (3.11–13.90)
FHD & age 1 2.20 (1.35–3.58) 4.65 (2.87–7.52) 1 1.67 (0.87–3.20) 4.68 (2.39–9.18) 1 2.78 (1.29–6.01) 5.17 (2.42–11.0)
FHD & age & triglycerides 1 1.89 (1.15–3.09) 3.89 (2.39–6.32) 1 1.31 (0.67–2.56) 3.82 (1.93–7.55) 1 2.54 (1.17–5.51) 4.46 (2.07–9.60)
FHD & age & triglycerides & systolic blood pressure 1 1.76 (1.07–2.89) 3.54 (2.16–5.79) 1 1.2 (0.62–2.40) 3.52 (1.76–7.04) 1 2.43 (1.12–5.29) 4.15 (1.92–8.97)
Population attributable risk (%) (95% CI) 23.3 (21.3–25.3) 37.1 (36.2–37.9) 7.8 (3.8–11.8) 26.6 (24.6–28.7) 35.3 (31.7–38.8) 48.34 (47.1–49.6)BMC Public Health 2007, 7:328 http://www.biomedcentral.com/1471-2458/7/328
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from the Health Professional Follow-Up Study [8], and
the Nurses Health Study [9] which showed that age-
adjusted relative risk for incident diabetes was higher in
women than men across the spectrum of BMI. Despite
these explanations, however, incidence of DM is almost
equal between sexes (3.7% in men vs. 3.9% in women).
There are some explanations for this finding; first, abso-
lute weight gain and increase in waist circumference, dur-
ing the 3.6 years follow-up period, in men were greater
than women. These changes among men may describe
why the incidence of diabetes in men was almost similar
to women despite higher proportions of obesity in
women. Second, men were somewhat older than women
were. Last but not least, the lost-to-follow-up rate was
higher in women than in men. That is, some of the
women who developed diabetes had been lost (data not
shown).
Despite the strong association between excess weight and
developing diabetes, only a few studies have reported esti-
mates of the risk of diabetes attributable to overweight
and obesity [17,24]. In the study of a Scottish population,
population attributable risk percentages comparing those
who were in the high normal weight group or above, to
those in the low normal weight group (18.5 to < 22.5 kg/
m2) were around 60% [17]. The estimated population
attributable risk of the effect of obesity on incident diabe-
tes was considerable in our study, showing that thirty per-
cent of the disease burden of diabetes in our population
was due to obesity. Since diabetes is indeed a preventable
disease, the causal relationship of the obesity with diabe-
tes is well established and it is conceivable that obesity can
be eliminated, the population attributable fraction is an
appropriate measure to be used by health policy officials
for future strategies.
Regarding both the strengths and limitations of our study,
the main strength of our study is a large sample sized pop-
ulation-based prospective study; in this cohort, we clearly
showed an independent role for overweight and obesity
in the development of diabetes. In addition, given the
population-based design of our study, it enabled the
impact of overweight and obesity to be estimated in terms
of their population attributable risk, which can help poli-
cymakers to implement appropriate programs to prevent
diabetes. The several limitations of our analysis also
deserve comment. First, we could not adjust some con-
founding variables such as physical activity, socio-eco-
nomic status, and dietary habit. Second, since the number
of cases of incident diabetes in subjects with normal BMI
was relatively low, we were unable to show possible
trends across normal BMI category. Third, we have used
weight and height measured at a particular point in time;
it is possible that some participants who were under-
weight or had normal weight at the baseline assessment
will have increased weight in the intervening period or
vice versa. The results of this would be to dilute any effect
of the true association. Last but not least, the main limita-
tion, a considerable fraction of subjects were lost during
the follow-up period; it is possible that some participants
who developed incident diabetes were among those lost,
which might influence our estimates. Furthermore,
because those who lost to follow-up were relatively
healthier, we may overestimate the population attributa-
ble risk.
Our estimate is quite less than that of other long-term
studies [17,24,26] which estimated population attributa-
ble risk for diabetes associated with excess weight. This
estimate may be less if we could adjust for further risk fac-
tors of diabetes including physical activity, socio-eco-
nomic status, and dietary habit. This implies that in short-
term intervals, contribution of other risk factors such as
smoking, physical activity, poor diet, and weight change
may be more important compared to long-term follow-up
[26]; this may be noticeable particularly in men. Accord-
ingly, one may speculate that in order to implement short-
term preventive strategies, paying more attention to other
risk factors of diabetes might be reasonable.
Conclusion
In summary, our results indicate that incident type 2 DM
is largely attributable to excess weight. In other words, our
quantification shows that over 60% disease burden of dia-
betes in our population is attributable to overweight and
obesity. This pattern is strongest in women as compared
to men. Therefore, prevention of excess weight needs to be
prioritized as a major strategy for reducing incidence of
type 2 DM in our population.
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